![Richard Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 159 733 $ al 30/09/2026
Richard Peters was the founder of MedNav, Inc. (1997), serving as Chief Executive Officer from 1997 to 2003.
Dr. Peters was the founder of PIC Therapeutics, Inc. (2016), serving as Director from 2016 to 2022.
Dr. Peters is the founder of Tellbio, Inc. (2019), serving as Executive Chairman since 2019.
Dr. Peters is the founder of X4 Pharmaceuticals, Inc. with founding dates listed as 2010 and 2014, with no titles specified.
Dr. Peters is currently President, Chief Executive Officer & Director at Yumanity, Inc. Dr. Peters is Chairman at Pharming Group NV since 2023.
Dr. Peters is Chairman at Aprea Therapeutics, Inc. since 2023.
Dr. Peters was President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc. from 2017 to 2019.
Dr. Peters was President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc. from 2020 to 2022.
Dr. Peters was Director-Medical Affairs at Amgen, Inc. from 2003 to 2006.
Dr. Peters was Senior Director at Onyx Pharmaceuticals, Inc. from 2006 to 2008.
Dr. Peters was Lead Independent Director at Kineta, Inc. from 2022 to 2025.
Dr. Peters was Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
from 2008 to 2017.
Dr. Peters earned a doctorate from The Medical University of South Carolina.
Dr. Peters completed undergraduate studies at the College of Charleston.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARMING GROUP NV 0,02 % | 28/05/2026 | 156.186 ( 0,02 % ) | 157 393 $ | 30/09/2026 |
APREA THERAPEUTICS, INC. 0,02 % | 16/06/2026 | 3.119 ( 0,02 % ) | 2 339 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| APREA THERAPEUTICS, INC. | Presidente | 23/08/2023 |
| PHARMING GROUP N.V. | Presidente | 25/09/2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Director Ejecutivo | - |
Tellbio, Inc.
 Tellbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops circulating tumor cell diagnostic technologies for detection, monitoring and treatment of cancer | Fundador | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| KINETA, INC. | Director/Miembro de la Junta | 30/06/2025 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Fundador | 01/06/2022 |
| YUMANITY THERAPEUTICS | Director Ejecutivo | 01/01/2022 |
| MERRIMACK PHARMACEUTICALS | Director Ejecutivo | 28/06/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Charleston
 College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services Develops mobile health applications | Technology Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Tellbio, Inc.
Tellbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops circulating tumor cell diagnostic technologies for detection, monitoring and treatment of cancer | Commercial Services |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
